Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tedizolid Phosphate (200mg) Tablet
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x1x6
Price
₹990/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tedizool Tablet contains Tedizolid Phosphate 200mg, a next-generation oxazolidinone-class antibiotic that acts as a prodrug, converting in vivo to its active form, tedizolid, after oral administration. It exerts its antibacterial action by inhibiting protein synthesis through binding to the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. Tedizolid shows potent activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus species, and vancomycin-resistant Enterococci (VRE). With once-daily dosing and a favorable safety profile, it serves as a convenient oral treatment alternative to injectable antibiotics in skin and soft tissue infections.
Common side effects include nausea, headache, diarrhea, dizziness, and vomiting. Serious but rare adverse effects may include myelosuppression, peripheral neuropathy, or optic neuropathy, especially with prolonged use. Tedizolid should be used with caution in patients with pre-existing hematologic disorders.
Tedizool Tablet is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive microorganisms, including drug-resistant strains such as MRSA and VRE.
Tedizool should only be taken under the supervision of a qualified healthcare professional. It is not intended for viral infections (e.g., flu, common cold). Prolonged or inappropriate use may lead to bacterial resistance. Blood counts should be monitored during extended therapy. Caution is advised in patients on serotonergic agents due to potential for serotonin syndrome.
Store below 25°C in a dry place, away from sunlight and moisture. Keep out of reach of children.
Composition : Clindamycin (300mg)
Composition : Amoxycillin Trihydrate I.P. 250mg + Cloxacillin I.P. 250mg + Lactic Acid Bacillus 1.7 Billion Spores
Composition : Amoxycillin (500mg)
Composition : Amoxycillin (250mg)
Composition : Cephalexin (500mg)
Composition : Doxycycline (100mg) + Lactobacillus (5Billion Spores)
Composition : Rifaximin (400mg)
Composition : Rifaximin (200mg) + Metronidazole (400mg)
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Ofloxacin (200mg) + Ornidazole (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tedizolid Phosphate 200mg Tablet has growing demand in the infectious diseases, dermatology, hospital care, and specialty anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced antibiotic and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from increasing demand for advanced antibiotic therapy under specialist medical supervision. Tedizolid Phosphate 200mg is an oxazolidinone-class antibiotic that inhibits bacterial protein synthesis and is effective against a range of susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and certain streptococci Commonly indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organisms, as advised by healthcare professionals and treatment guidelines Offers the convenience of once-daily oral dosing, which may help improve patient adherence when clinically appropriate Should be used only for suspected or confirmed bacterial infections caused by susceptible organisms to support antimicrobial stewardship and help reduce the development of antibiotic resistance Patients should be monitored for clinical response and potential adverse effects, particularly during prolonged therapy or when used with medicines that may interact with oxazolidinone antibiotics, under medical supervision Frequently utilized in hospitals, infectious disease clinics, dermatology practices, and specialty healthcare centers Widely prescribed by infectious disease specialists, dermatologists, surgeons, and general physicians for appropriate bacterial skin infections This strengthens a comprehensive specialty anti-infective and hospital care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tedizolid Phosphate 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from growing demand for advanced antibiotics, strong hospital and specialty care market opportunities, reliable supply chain support, repeat procurement, and attractive margins in the specialty anti-infective segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality specialty pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.